Trial Profile
Retrospective study of long-term effectiveness of infliximab (IFX) in ulcerative colitis (UC) patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 19 May 2016 New trial record